ES2091369T3 - Antibioticos glucopeptidicos derivados de balhimicina. - Google Patents
Antibioticos glucopeptidicos derivados de balhimicina.Info
- Publication number
- ES2091369T3 ES2091369T3 ES92110823T ES92110823T ES2091369T3 ES 2091369 T3 ES2091369 T3 ES 2091369T3 ES 92110823 T ES92110823 T ES 92110823T ES 92110823 T ES92110823 T ES 92110823T ES 2091369 T3 ES2091369 T3 ES 2091369T3
- Authority
- ES
- Spain
- Prior art keywords
- balhimycin
- compound
- formula
- glucopeptidic
- antibiotics derived
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
- C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
TIENE EFECTO ANTIBIOTICO EL METIL MBINACION DE LA FORMULA C65 H71 CL2 N9 O24, EL METILLEUCIL BALHIMICIN Y UNA COMPOSICION DE LA FORMULA C59 H60 CL2 N8 O23, EL GLUCO L2 N9 O19, UREIDO LA C67 H74 CL2 N10 O25, EL METIL 5 Y UNA COMPOSICION DE LA FORMULA C73 H84 CL2 N10 O26, UNA COMPOSICION METIL BALHIMICIIN R DE UNA COMPOSICION DE LA FORMULA C72 H83 CL2 N9 O28.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4121662A DE4121662A1 (de) | 1991-06-29 | 1991-06-29 | Neue glycopeptide, verfahren zu ihrer herstellung und ihre verwendung |
DE4134611 | 1991-10-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2091369T3 true ES2091369T3 (es) | 1996-11-01 |
Family
ID=25905082
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES92110823T Expired - Lifetime ES2091369T3 (es) | 1991-06-29 | 1992-06-26 | Antibioticos glucopeptidicos derivados de balhimicina. |
Country Status (23)
Country | Link |
---|---|
US (1) | US5763397A (es) |
EP (1) | EP0521408B1 (es) |
JP (1) | JP2959911B2 (es) |
KR (1) | KR100243962B1 (es) |
AT (1) | ATE142226T1 (es) |
AU (2) | AU660682B2 (es) |
CA (1) | CA2072725A1 (es) |
CZ (1) | CZ284310B6 (es) |
DE (1) | DE59207033D1 (es) |
DK (1) | DK0521408T3 (es) |
ES (1) | ES2091369T3 (es) |
FI (1) | FI106032B (es) |
GR (1) | GR3021042T3 (es) |
HR (1) | HRP920191B1 (es) |
HU (1) | HU214057B (es) |
IE (1) | IE74901B1 (es) |
IL (1) | IL102326A (es) |
NO (1) | NO306950B1 (es) |
NZ (1) | NZ243345A (es) |
RU (1) | RU2099349C1 (es) |
SI (1) | SI9200126A (es) |
TW (1) | TW213468B (es) |
YU (1) | YU48512B (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19523394A1 (de) * | 1995-06-28 | 1997-01-09 | Hoechst Ag | Verwendung von Balhimycin zur Leistungssteigerung bei Tieren sowie leistungssteigernde Mittel |
US5977063A (en) * | 1997-05-20 | 1999-11-02 | Eli Lilly And Company | Alkylated hexapeptides |
US5919771A (en) * | 1997-05-20 | 1999-07-06 | Eli Lilly And Company | Urea and thiourea derivatives of glycopeptides |
US5952310A (en) * | 1997-05-20 | 1999-09-14 | Eli Lilly And Company | Glycopeptide hexapeptides |
DE19926770A1 (de) | 1999-06-11 | 2000-12-14 | Basf Ag | Nukleinsäurefragment und Vektor, enthaltend eine Halogenase, sowie ein Verfahren zur Halogenierung chemischer Verbindungen |
US6696412B1 (en) | 2000-01-20 | 2004-02-24 | Cubist Pharmaceuticals, Inc. | High purity lipopeptides, Lipopeptide micelles and processes for preparing same |
US20060014674A1 (en) | 2000-12-18 | 2006-01-19 | Dennis Keith | Methods for preparing purified lipopeptides |
EP1908770B2 (en) * | 2000-12-18 | 2015-07-15 | Cubist Pharmaceuticals, Inc. | Methods for preparing purified lipopeptides |
US9820986B2 (en) * | 2005-03-04 | 2017-11-21 | Taiwan Hopaz Chems, Mfg. Co., Ltd. | Glycopeptide compositions |
US8835382B2 (en) | 2009-11-23 | 2014-09-16 | Cubist Pharmaceuticals, Inc. | Lipopeptide compositions and related methods |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4584300A (en) * | 1983-02-07 | 1986-04-22 | Santen Pharmaceutical Co., Ltd. | Platelet anti-aggregative- and calcium antagonistic -1,4-benzothiazin-3-one derivatives, compositions, and methods of use therefor |
DE3420596C2 (de) * | 1984-06-01 | 1986-10-02 | Dr.-Ing. Ludwig Pietzsch Gmbh & Co, 7505 Ettlingen | Überwachungs- und Steuersystem für Auslegerkrane |
JPH0662674B2 (ja) * | 1985-01-11 | 1994-08-17 | 三共株式会社 | 抗生物質クロロポリスポリンbまたはc |
DE3702758A1 (de) * | 1987-01-30 | 1988-09-29 | Hoechst Ag | Substituierte 3-phenyl-7h-thiazolo (3,2-b) (1,2,4) triazin-7-one, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung, sowie einige bei der herstellung der genannten verbindungen gebildete zwischenprodukte |
DE3713757A1 (de) * | 1987-04-24 | 1988-11-10 | Hoechst Ag | Benzolsulfonamidderivate und verfahren zu ihrer herstellung |
NZ236393A (en) * | 1989-12-13 | 1992-05-26 | Lilly Co Eli | N-alkylated glycopeptide derivatives prepared from antibiotics a82846 series and pa-42867-a; pharmaceutical compositions |
IN171883B (es) * | 1990-07-27 | 1993-01-30 | Hoechst India |
-
1992
- 1992-01-28 TW TW081100587A patent/TW213468B/zh active
- 1992-06-11 YU YU60392A patent/YU48512B/sh unknown
- 1992-06-25 FI FI922954A patent/FI106032B/fi active
- 1992-06-26 NO NO922520A patent/NO306950B1/no unknown
- 1992-06-26 HR HRP4134611.4A patent/HRP920191B1/xx not_active IP Right Cessation
- 1992-06-26 AU AU18575/92A patent/AU660682B2/en not_active Ceased
- 1992-06-26 NZ NZ243345A patent/NZ243345A/en unknown
- 1992-06-26 CZ CS921991A patent/CZ284310B6/cs not_active IP Right Cessation
- 1992-06-26 JP JP4168698A patent/JP2959911B2/ja not_active Expired - Fee Related
- 1992-06-26 IL IL10232692A patent/IL102326A/en not_active IP Right Cessation
- 1992-06-26 RU SU925052120A patent/RU2099349C1/ru active
- 1992-06-26 DK DK92110823.9T patent/DK0521408T3/da active
- 1992-06-26 ES ES92110823T patent/ES2091369T3/es not_active Expired - Lifetime
- 1992-06-26 DE DE59207033T patent/DE59207033D1/de not_active Expired - Fee Related
- 1992-06-26 AT AT92110823T patent/ATE142226T1/de not_active IP Right Cessation
- 1992-06-26 EP EP92110823A patent/EP0521408B1/de not_active Expired - Lifetime
- 1992-06-27 KR KR1019920011319A patent/KR100243962B1/ko not_active IP Right Cessation
- 1992-06-29 SI SI19929200126A patent/SI9200126A/sl unknown
- 1992-06-29 US US07/907,747 patent/US5763397A/en not_active Expired - Fee Related
- 1992-06-29 CA CA002072725A patent/CA2072725A1/en not_active Abandoned
- 1992-06-29 HU HU9202163A patent/HU214057B/hu not_active IP Right Cessation
- 1992-07-01 IE IE922115A patent/IE74901B1/en not_active IP Right Cessation
-
1995
- 1995-10-05 AU AU33089/95A patent/AU687612B2/en not_active Ceased
-
1996
- 1996-09-13 GR GR960402401T patent/GR3021042T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69100865D1 (de) | 1,4,8-Triazacyclotridecan-Derivate mit Prolylendopeptidase-hemmender Wirkung. | |
ES2091369T3 (es) | Antibioticos glucopeptidicos derivados de balhimicina. | |
NO174517C (es) | ||
ES2054927T3 (es) | Antibioticos glicosidicos bu-3608 d y bu-3608 e. | |
DE68923928D1 (de) | Glykopeptid-Antibiotika. | |
FI922437A0 (fi) | Tetracykliska antibiotika och foerfarande foer framstaellning av dessa. | |
NO910309D0 (no) | Fremgangsmaate for fremstilling samt anvedelse av et nytt antibiotisk deoksymulundocandin. | |
IN171883B (es) | ||
IN172911B (es) | ||
RU1808695C (ru) | Центрирующее захватное устройство | |
ES2111018T3 (es) | Antibiotico ll-e19020 gamma. | |
ATE161847T1 (de) | Antibiotikum ll-e19020 alpha | |
ITMI910660A1 (it) | Anticorpi monoclonali come antidoti | |
SE8403352D0 (sv) | Desacetylravidomycin | |
SU1823451A1 (ru) | 2,3а-Дигидрокси-3-(4-толуоил)-3а,4-дигидро-1Н-пирроло[2,1-с][1, 4]бензоксазин-1,4-дион, проявляющий противомикробную активность в отношении кокковых форм бактерий |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 521408 Country of ref document: ES |